Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 2023-02, Vol.180, p.85-88
Hauptverfasser:	Kasper, Stefan, Foch, Caroline, Esser, Regina, Lamy, Francois-Xavier, Zhang, Aimar, Cheng, Ann-Lii, Rouyer, Magali, Brodowicz, Thomas, Zielinski, Christoph
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Immunological - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cetuximab - therapeutic use Colonic Neoplasms - drug therapy Colorectal carcinoma Colorectal Neoplasms - drug therapy Colorectal Neoplasms - genetics Humans Metastases Proto-Oncogene Proteins p21(ras) Rectal Neoplasms - drug therapy Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!